• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Per-Se Technologies forms dedicated e-health division

Article

Clinical software and systems developer Per-Se Technologies has formed a separate division called Per-Se e-Health. Per-Se e-Health will offer private network and Internet-based business-to-business

Clinical software and systems developer Per-Se Technologies has formed a separate division called Per-Se e-Health. Per-Se e-Health will offer private network and Internet-based business-to-business e-health products to physicians throughout the U.S. The Atlanta-based company already provides e-health services to more than 33,000 physicians, with a focus on hospital-affiliated physicians such as radiologists, anesthesiologists, emergency medicine physicians, pathologists, and academic institutions and certain surgical specialties. Per-Se says its national database of processed claims offers unique Web-based decision support that enhances healthcare practices.

© 2000 Miller Freeman, Inc., a United News & Media company.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.